CGEM
Cullinan Oncology LLC
21.70$
+1.5%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 56.0% | 38.8% | 100.0% | 100.0% | 98.8% | 99.6% | 98.9% | 67.8% | 84.6% | 99.2% | 66.7% | 86.3% | |
| 10.0% | 13.3% | 100.0% | 2.6% | 97.7% | 63.0% | 78.3% | 13.7% | 27.8% | 20.3% | 13.3% | 19.7% | |
| – | – | – | – | 97.7% | 98.2% | 97.9% | 66.4% | 83.3% | 96.5% | 64.2% | 84.3% | |
| 23.8% | 9.2% | – | 97.4% | – | – | – | – | – | 1.1% | 0.5% | – | |
| – | – | – | – | – | – | – | – | – | -1.1% | – | – | |
| – | – | – | – | 0.7% | 0.2% | 0.1% | 0.0% | 0.2% | – | – | – | |
| 4,517.7% | 7,047.1% | 1,055,014.4% | 16,835.1% | 159.6% | 139.7% | 6.7% | 2.7% | 4.6% | 6.3% | 5.1% | 8.8% | |
| 240.3% | 522.8% | 132,832.2% | 7,216.2% | 3.8% | 2.5% | 6.7% | 2.7% | 4.0% | 5.8% | 4.9% | 8.4% | |
| 4,277.3% | 6,524.3% | 922,182.2% | 9,618.9% | – | – | – | – | 0.3% | 0.3% | 0.2% | 0.2% | |
| 240.3% | 522.8% | 132,832.2% | 7,216.2% | 0.9% | 0.9% | 4.5% | 0.7% | 0.5% | 0.5% | 0.3% | 0.2% | |
| 4,277.3% | 6,524.3% | 922,182.2% | 9,618.9% | – | – | – | – | – | – | – | – | |
| -4,417.7% | -6,947.1% | -1,054,914.4% | -16,735.1% | -59.6% | -40.6% | 92.7% | 97.2% | 95.4% | 93.7% | 94.9% | 91.2% | |
| -11,413.6% | -16,683.6% | -2,403,344.9% | -91,780.2% | -60.2% | -41.3% | -43.5% | -36.3% | -8.5% | -41.5% | -59.2% | -131.2% | |
| – | – | – | – | 2.3% | 1.0% | 20.3% | 10.1% | 8.3% | 8.6% | 8.6% | 13.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.